| Title |
Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study
|
|---|---|
| Published in |
Psychopharmacology, May 2007
|
| DOI | 10.1007/s00213-007-0792-1 |
| Pubmed ID | |
| Authors |
Gerry Jager, Maartje M. de Win, Hylke K. Vervaeke, Thelma Schilt, Rene S. Kahn, Wim van den Brink, Jan M. van Ree, Nick F. Ramsey |
| Abstract |
Heavy ecstasy use in humans has been associated with cognitive impairments and changes in cognitive brain function supposedly due to damage to the serotonin system. There is concern that even a single dose of 3,4-methylenedioxymethamphetamine may be neurotoxic, but very little is known about the consequences of a low dose of ecstasy for cognitive brain function. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Canada | 2 | 2% |
| Netherlands | 1 | <1% |
| Chile | 1 | <1% |
| Unknown | 99 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 19 | 18% |
| Student > Master | 15 | 14% |
| Researcher | 11 | 10% |
| Student > Bachelor | 10 | 10% |
| Other | 8 | 8% |
| Other | 14 | 13% |
| Unknown | 28 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 19 | 18% |
| Neuroscience | 16 | 15% |
| Medicine and Dentistry | 14 | 13% |
| Agricultural and Biological Sciences | 6 | 6% |
| Social Sciences | 4 | 4% |
| Other | 15 | 14% |
| Unknown | 31 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2012.
All research outputs
#6,379,364
of 22,668,244 outputs
Outputs from Psychopharmacology
#1,834
of 5,330 outputs
Outputs of similar age
#22,467
of 72,089 outputs
Outputs of similar age from Psychopharmacology
#6
of 19 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 5,330 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.